Table 1.
COVID-19 Cases Reported in the SECURE-IBD Registry | COVID-19 Cases Reported in the Countries or States Reporting in the SECURE-IBD Registry | Proportion of COVID-19 Cases reported to the SECURE-IBD (per 100 000)∗ | |
---|---|---|---|
World∗∗ | 6,404 | 178,155,029 | 3.59 (3.51, 3.68) |
Africa | 29 | 3,944,809 | 0.74 (0.49, 1.06) |
Asia | 412 | 50,300,051 | 0.82 (0.73, 0.90) |
Europe | 3,110 | 48,398,556 | 6.43 (6.20, 6.66) |
Latin America | 342 | 39,057,623 | 0.47 (0.76, 0.97) |
North America | 2,416 | 36,416,733 | 6.63 (6.37, 6.90) |
Oceania | 13 | 37,257 | 34.89 (18.58, 59.66) |
United States∗∗∗ | 2,231 | 34,817,970 | 6.41 (6.14, 6.68) |
Midwest | 681 | 7,495,739 | 9.09 (8.42, 9.79) |
Northeast | 596 | 5,843,208 | 10.20 (9.40, 11.05) |
South | 629 | 13,823,528 | 4.55 (4.20, 4.92) |
West | 254 | 7,655,495 | 3.32 (2.92, 3.75) |
∗Proportion of COVID-19 cases reported to the SECURE-IBD registry relative to all COVID-19 cases in the general population among countries or states reporting data into the SECURE-IBD registry (per 100,000).
∗∗826 reported cases of COVID-19 in patients with IBD did not report the country of origin.
∗∗∗Five reported cases of COVID-19 in patients with IBD were from United States territories outside of the 4 regions listed here.